Friday, 6 November 2026European Markets

Currency Markets

5 articles

U.S. 10-Year Yield Reaches 5.0% as Dual Bond Selloff Pressures European Tech Valuations

U.S. 10-Year Yield Reaches 5.0% as Dual Bond Selloff Pressures European Tech Valuations

The U.S. 10-Year Treasury yield has climbed from 4.31% to 5.0%, while Japan's equivalent benchmark rose from 2.478% to 2.641%, signalling a coordinated global bond repricing. For European markets, the shift raises borrowing costs for capital-intensive AI infrastructure and reinforces dollar strength against the euro. High-multiple tech and AI companies face the steepest valuation headwinds as discount rates rise.

LM Salvado•
Euro Surges 14% Against Dollar as Sterling Drops to €1.13 Two-Year Low

Euro Surges 14% Against Dollar as Sterling Drops to €1.13 Two-Year Low

The euro appreciated 14% in 2025 while the U.S. Dollar Index tumbled 10.8% in early 2026, driving major currency realignment across European markets. The British pound fell 0.4% to €1.13—its lowest level since April 2023—despite gaining 7% against the dollar in 2025, as analysts warn of further pressure toward $1.30.

LM Salvado•
Euro Surges 14% Against Dollar in 2025, Testing ECB Export Strategy

Euro Surges 14% Against Dollar in 2025, Testing ECB Export Strategy

The euro has climbed 14% against the dollar in 2025, reaching its strongest level since 2022 as dollar weakness reshapes global currency markets. The surge puts pressure on eurozone exporters facing reduced competitiveness, while the European Central Bank navigates policy tensions between controlling inflation and supporting export-driven economies. Sterling has gained 7% against the greenback in the same period.

ViaNews Editorial Team (Europe)•
Euro Surges 14% Against Dollar as Currency Reversal Hits European Exporters

Euro Surges 14% Against Dollar as Currency Reversal Hits European Exporters

The Euro has gained 14% against the dollar in 2025, reaching its strongest level since 2022 as the US currency hits multi-year lows. The sharp appreciation threatens European exporters' competitiveness while boosting purchasing power for EU imports. Currency analysts expect further dollar weakness, with traders positioning the Swiss Franc as a systemic hedge amid high volatility.

ViaNews Editorial Team (Europe)•
Euro Hits $1.13, 14-Year High Against Dollar as European Exporters Gain Pricing Power

Euro Hits $1.13, 14-Year High Against Dollar as European Exporters Gain Pricing Power

The euro reached €1.13 against the British pound, its strongest level since April 2023, as the dollar fell to its lowest point since 2022. The euro has appreciated 14% against the dollar in 2025, strengthening European manufacturers' competitive position in global markets. Currency shifts stem from Federal Reserve leadership uncertainty ahead of Jerome Powell's June 2026 replacement and ongoing US policy debates.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com